{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:30:29Z","timestamp":1793961029845,"version":"4.8.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.eprac.2026.06.011","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:46:46Z","timestamp":1788850006000},"page":"1601-1616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["American Association of Clinical Endocrinology Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes"],"prefix":"10.1016","volume":"32","author":[{"given":"Janet B.","family":"McGill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy C.","family":"Donihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halis K.","family":"Akturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Freeby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhinav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William B.","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Nauman","family":"Jadoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanam","family":"Lathief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigfrido","family":"Miracle-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charity","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib1","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","article-title":"American Association of Clinical Endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus","volume":"27","author":"Grunberger","year":"2021","journal-title":"Endocr Pract"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2026.06.011_bib2","doi-asserted-by":"crossref","first-page":"S150","DOI":"10.2337\/dc26-S007","article-title":"7. Diabetes technology: Standards of Care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.eprac.2026.06.011_bib3","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the International Consensus on Time in Range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.06.011_bib4","article-title":"Expert panel recommendations for use of standardized glucose reporting system based on standardized glucometrics plus visual ambulatory glucose profile (AGP) data in clinical practice","volume":"12","author":"Dagdelen","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2026.06.011_bib5","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.2337\/dc26-S006","article-title":"6. Glycemic goals, hypoglycemia, and hyperglycemic crises: Standards of Care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib7","first-page":"537","article-title":"Continuous glucose monitoring in type 1 diabetes, type 2 diabetes, and diabetes during pregnancy: a systematic review with meta-analysis of randomized controlled trials","volume":"27","author":"Rizos","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib8","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc23-1581","article-title":"Time in tight glucose range in type 1 diabetes: predictive factors and achievable targets in real-world users of the MiniMed 780G system","volume":"47","author":"Casta\u00f1eda","year":"2024","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/dia.2023.0565","article-title":"Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes","volume":"26","author":"Dunn","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.eprac.2026.06.011_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14854","article-title":"Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials","volume":"39","author":"Elbalshy","year":"2022","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00125-021-05648-4","article-title":"Effectiveness of continuous glucose monitoring in maintaining glycaemic control among people with type 1 diabetes mellitus: a systematic review of randomised controlled trials and meta-analysis","volume":"65","author":"Teo","year":"2022","journal-title":"Diabetologia"},{"issue":"22","key":"10.1016\/j.eprac.2026.06.011_bib12","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.eprac.2026.06.011_bib13","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1001\/jama.2021.6530","article-title":"Association of real-time continuous glucose monitoring with glycemic control and acute metabolic events among patients with insulin-treated diabetes","volume":"325","author":"Karter","year":"2021","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/clinem\/dgad652","article-title":"Effectiveness of continuous glucose monitoring on metrics of glycemic control in type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials","volume":"109","author":"Uhl","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/dom.15328","article-title":"Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: a systematic review and network meta-analysis of randomized controlled trials","volume":"26","author":"Lu","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"11","key":"10.1016\/j.eprac.2026.06.011_bib16","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1111\/dom.70008","article-title":"Continuous glucose monitoring in noninsulin-treated type 2 diabetes: a critical review of reported trials with an updated systematic review and meta-analysis of randomised controlled trials","volume":"27","author":"Aronson","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1089\/dia.2023.0390","article-title":"Continuous glucose monitoring systems in noninsulin-treated people with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"26","author":"Ferreira","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","year":"2024","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.eprac.2026.06.011_bib19","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1111\/dom.15866","article-title":"Impact of continuous glucose monitoring on hospitalizations and glucose control in people with type 2 diabetes: real-world analysis","volume":"26","author":"Garg","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib20","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1177\/15209156251414980","article-title":"Clinical impact of continuous glucose monitoring in noninsulin treated type 2 diabetes: a review","volume":"28","author":"Aleppo","year":"2026","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.eprac.2026.06.011_bib21","doi-asserted-by":"crossref","DOI":"10.1177\/19322968251384318","article-title":"Continuous glucose monitoring to guide lifestyle choices with a focus on nutrition in the management of type 2 diabetes: a systematic review and meta-analysis","author":"Bannuru","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/19322968241292041","article-title":"Consensus report on the use of continuous glucose monitoring in chronic kidney disease and diabetes","volume":"19","author":"Rhee","year":"2025","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.2337\/dc25-2952","article-title":"Accuracy, variability, and bias of glycemic biomarkers in patients treated with maintenance dialysis","volume":"49","author":"Zelnick","year":"2026","journal-title":"Diabetes Care"},{"issue":"5s","key":"10.1016\/j.eprac.2026.06.011_bib24","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/19322968251364276","article-title":"Wearable diabetes technology for hospitalized people with diabetes and end-stage kidney disease, peripartum state, and steroid use","volume":"20","author":"Agarwal","year":"2026","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib26","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1210\/endrev\/bnac003","article-title":"A clinical update on gestational diabetes mellitus","volume":"43","author":"Sweeting","year":"2022","journal-title":"Endocr Rev"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2026.06.011_bib27","doi-asserted-by":"crossref","first-page":"S321","DOI":"10.2337\/dc26-S015","article-title":"15. Management of diabetes in pregnancy: Standards of Care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S2213-8587(25)00335-3","article-title":"Application of continuous glucose monitoring and automated insulin delivery technologies for pregnant women with type 1, type 2, or gestational diabetes: an international consensus statement","volume":"14","author":"Benhalima","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib29","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.eprac.2022.08.002","article-title":"American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update","volume":"28","author":"Blonde","year":"2022","journal-title":"Endocr Pract"},{"issue":"8","key":"10.1016\/j.eprac.2026.06.011_bib30","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.2337\/dc24-2494","article-title":"Lack of validity of the glucose management indicator in type 1 diabetes in pregnancy","volume":"48","author":"Meek","year":"2025","journal-title":"Diabetes Care"},{"issue":"10110","key":"10.1016\/j.eprac.2026.06.011_bib31","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.eprac.2026.06.011_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s00592-026-02644-1","article-title":"Continuous glucose monitoring versus self-monitoring of blood glucose in gestational diabetes: an updated systematic review and meta-analysis of randomized controlled trials","author":"Gautam","year":"2026","journal-title":"Acta Diabetol"},{"issue":"9","key":"10.1016\/j.eprac.2026.06.011_bib33","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.2337\/dc25-0115","article-title":"Real-time continuous glucose monitoring in pregnancies with gestational diabetes mellitus: a randomized controlled trial","volume":"48","author":"Valent","year":"2025","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib34","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S2213-8587(25)00063-4","article-title":"Continuous glucose monitoring in the management of gestational diabetes in Switzerland (DipGluMo): an open-label, single-centre, randomised, controlled trial","volume":"13","author":"Amylidi-Mohr","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15452","article-title":"Using technology to support diabetes care in hospital: guidelines from the Joint British Diabetes Societies for Inpatient Care (JBDS-IP) group and Diabetes Technology Network (DTN) UK","volume":"42","author":"Avari","year":"2025","journal-title":"Diabet Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/1932296820954163","article-title":"Continuous glucose monitors and automated insulin dosing systems in the hospital consensus guideline","volume":"14","author":"Galindo","year":"2020","journal-title":"J Diabetes Sci Technol"},{"issue":"8","key":"10.1016\/j.eprac.2026.06.011_bib37","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1210\/clinem\/dgac278","article-title":"Management of hyperglycemia in hospitalized adult patients in non-critical care settings: an Endocrine Society clinical practice guideline","volume":"107","author":"Korytkowski","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib38","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1097\/CCM.0000000000006174","article-title":"Society of Critical Care Medicine guidelines on glycemic control for critically ill children and adults 2024","volume":"52","author":"Honarmand","year":"2024","journal-title":"Crit Care Med"},{"issue":"Supplement_1","key":"10.1016\/j.eprac.2026.06.011_bib39","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.2337\/dc26-S016","article-title":"16. Diabetes care in the hospital: Standards of Care in Diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib40","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1007\/s00125-024-06206-4","article-title":"Technology in the management of diabetes in hospitalised adults","volume":"67","author":"Thabit","year":"2024","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib41","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/dc22-0716","article-title":"Continuous glucose monitoring-guided insulin administration in hospitalized patients with diabetes: a randomized clinical trial","volume":"45","author":"Spanakis","year":"2022","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.eprac.2026.06.011_bib42","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.2337\/dc19-2073","article-title":"Comparison of the FreeStyle Libre Pro flash continuous glucose monitoring (CGM) system and point-of-care capillary glucose testing in hospitalized patients with type 2 diabetes treated with basal-bolus insulin regimen","volume":"43","author":"Galindo","year":"2020","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib43","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3803\/EnM.2024.1951","article-title":"Glucocorticoid-induced hyperglycemia: a neglected problem","volume":"39","author":"Cho","year":"2024","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"11","key":"10.1016\/j.eprac.2026.06.011_bib44","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.eprac.2023.06.007","article-title":"Accuracy and potential interferences of continuous glucose monitoring sensors in the hospital","volume":"29","author":"Bellido","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.06.011_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111986","article-title":"Use of continuous glucose monitoring and point-of-care glucose testing in hospitalized patients with diabetes mellitus in non-intensive care unit settings: a systematic review and meta-analysis of randomized controlled trials","volume":"220","author":"Cavalcante Lima Chagas","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib46","doi-asserted-by":"crossref","first-page":"e2411","DOI":"10.1210\/clinem\/dgaf074","article-title":"Implementation strategies for inpatient continuous glucose monitoring-based diabetes management: a systematic review","volume":"110","author":"Olsen","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/dc24-1779","article-title":"Results from a randomized trial of intensive glucose management using CGM versus usual care in hospitalized adults with type 2 diabetes: the TIGHT study","volume":"48","author":"Hirsch","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.06.011_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2024.154894","article-title":"Continuous glucose monitoring versus conventional glucose monitoring in the ICU: a randomized controlled trial","volume":"84","author":"Chu","year":"2024","journal-title":"J Crit Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12933-025-02747-z","article-title":"Use of an insulin titration protocol based on continuous glucose monitoring in postoperative cardiac surgery patients with type 2 diabetes and prediabetes: a randomized controlled trial","volume":"24","author":"Moon","year":"2025","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.eprac.2025.02.007","article-title":"Continuous glucose monitoring in hospitalized patients with type 2 diabetes: a step forward in inpatient glycemic control","volume":"31","author":"Rivas-Montenegro","year":"2025","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.06.011_bib51","doi-asserted-by":"crossref","DOI":"10.2196\/67012","article-title":"Effectiveness of continuous glucose monitoring on short-term, in-hospital mortality among frail and critically ill patients with COVID-19: Randomized controlled trial","volume":"27","author":"Shang","year":"2025","journal-title":"J Med Internet Res"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib52","first-page":"4757","article-title":"Subcutaneous continuous glucose monitoring in critically ill patients during insulin therapy: a meta-analysis","volume":"14","author":"Yao","year":"2022","journal-title":"Am J Transl Res"},{"issue":"12","key":"10.1016\/j.eprac.2026.06.011_bib53","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.2337\/dci24-0073","article-title":"Consensus considerations and good practice points for use of continuous glucose monitoring systems in hospital settings","volume":"47","author":"Shaw","year":"2024","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib54","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1177\/19322968231191104","article-title":"A consensus statement for continuous glucose monitoring metrics for inpatient clinical trials","volume":"17","author":"Spanakis","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib55","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1007\/s11606-025-09449-y","article-title":"Expanding access to continuous glucose monitoring through empowering primary care: a joint endocrinology-primary care quality improvement project","volume":"40","author":"Flint","year":"2025","journal-title":"J Gen Intern Med"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib56","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/19322968211070855","article-title":"The benefits of utilizing continuous glucose monitoring of diabetes mellitus in primary care: a systematic review","volume":"17","author":"Kieu","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib58","doi-asserted-by":"crossref","DOI":"10.1093\/intqhc\/mzaf046","article-title":"Continuous glucose monitoring in type 2 diabetes: a systematic review of barriers and opportunities for care improvement","volume":"37","author":"Barchiesi","year":"2025","journal-title":"Int J Qual Health Care"},{"issue":"12","key":"10.1016\/j.eprac.2026.06.011_bib59","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/1753-0407.13454","article-title":"Patient experiences of continuous glucose monitoring and sensor-augmented insulin pump therapy for diabetes: a systematic review of qualitative studies","volume":"15","author":"Natale","year":"2023","journal-title":"J Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib61","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib62","doi-asserted-by":"crossref","first-page":"272","DOI":"10.17294\/2330-0698.1819","article-title":"Determining the perception and willingness of primary care providers to prescribe advanced diabetes technologies","volume":"8","author":"O\u2019Donovan","year":"2021","journal-title":"J Patient Cent Res Rev"},{"issue":"S3","key":"10.1016\/j.eprac.2026.06.011_bib63","first-page":"S48","article-title":"Registration and real-life studies on automated insulin delivery systems","volume":"27","author":"Akturk","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3842","article-title":"Efficacy and safety of different hybrid closed loop systems for automated insulin delivery in people with type 1 diabetes: a systematic review and network meta-analysis","volume":"40","author":"Di Molfetta","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"S3","key":"10.1016\/j.eprac.2026.06.011_bib65","first-page":"S60","article-title":"Research gaps, challenges, and opportunities in automated insulin delivery systems","volume":"27","author":"Jacobs","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib66","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1111\/dom.70355","article-title":"Impact of stepwise diabetes technology advances in older adults with type 1 diabetes: a systematic review and meta-analysis of randomised trials","volume":"28","author":"Lei","year":"2026","journal-title":"Diabetes Obes Metab"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib67","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1007\/s00125-024-06240-2","article-title":"Ageing well with diabetes: the role of technology","volume":"67","author":"Maltese","year":"2024","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib68","first-page":"572","article-title":"Automated insulin delivery in elderly with type 1 diabetes: a prespecified analysis of the extension phase","volume":"27","author":"Kudva","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib69","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400200","article-title":"Automated insulin delivery in older adults with type 1 diabetes","volume":"4","author":"Kudva","year":"2025","journal-title":"NEJM Evid"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2025.102026","article-title":"Use of advanced technology for the treatment of type 1 diabetes in pregnancy","volume":"39","author":"Geerts","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib71","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","article-title":"Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial","volume":"12","author":"Benhalima","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"24","key":"10.1016\/j.eprac.2026.06.011_bib72","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1001\/jama.2025.19578","article-title":"Closed-loop insulin delivery in type 1 diabetes in pregnancy: the CIRCUIT randomized clinical trial","volume":"334","author":"Donovan","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.eprac.2026.06.011_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112454","article-title":"Use of commercially available automated insulin delivery systems in pregnant people with type 1 diabetes","volume":"228","author":"Pham","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"17","key":"10.1016\/j.eprac.2026.06.011_bib74","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","article-title":"Automated insulin delivery in women with pregnancy complicated by type 1 diabetes","volume":"389","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.eprac.2026.06.011_bib75","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib76","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/dia.2024.0586","article-title":"Safety and effectiveness of MiniMed(TM) 780G advanced hybrid closed-loop insulin intensification in adults with insulin-requiring type 2 diabetes","volume":"27","author":"Bhargava","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.59348","article-title":"Automated insulin delivery in adults with type 2 diabetes: a nonrandomized clinical trial","volume":"8","author":"Pasquel","year":"2025","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41591-022-02144-z","article-title":"Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial","volume":"29","author":"Daly","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib79","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.2337\/dc25-2435","article-title":"Automated insulin delivery systems in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"49","author":"Hespanhol","year":"2026","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15196","article-title":"Does fully closed-loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta-analysis of randomized controlled trials","volume":"41","author":"Amer","year":"2024","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib81","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2337\/dc24-0623","article-title":"Closed-loop insulin therapy for people with type 2 diabetes treated with an insulin pump: a 12-week multicenter, open-label randomized, controlled, crossover trial","volume":"47","author":"Borel","year":"2024","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib82","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.kint.2019.03.006","article-title":"Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis","volume":"96","author":"Bally","year":"2019","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib83","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","article-title":"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","volume":"5","author":"Thabit","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2025.101637","article-title":"Practical implementation of automated insulin delivery systems in 2025: a French position statement update","volume":"51","author":"Bismuth","year":"2025","journal-title":"Diabetes Metab"},{"issue":"9","key":"10.1016\/j.eprac.2026.06.011_bib85","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.eprac.2025.05.752","article-title":"The future of automated insulin delivery systems","volume":"31","author":"Hughes","year":"2025","journal-title":"Endocr Pract"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib86","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.eprac.2026.03.097","article-title":"Automated insulin delivery systems in cystic fibrosis-related diabetes: a systematic review and meta-analysis","volume":"32","author":"Souza","year":"2026","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib87","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s40200-026-01864-0","article-title":"Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: the ACCESS-AID study protocol","volume":"25","author":"Gale","year":"2026","journal-title":"J Diabetes Metab Disord"},{"issue":"1 Suppl 1","key":"10.1016\/j.eprac.2026.06.011_bib88","first-page":"S321","article-title":"16. Diabetes care in the hospital: Standards of Care in Diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.eprac.2026.06.011_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinane.2024.111627","article-title":"Perioperative management of adult patients with diabetes wearing devices: a Society for Perioperative Assessment and Quality Improvement (SPAQI) expert consensus statement","volume":"99","author":"Oprea","year":"2024","journal-title":"J Clin Anesth"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib90","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1089\/dia.2023.0304","article-title":"Automated insulin delivery with remote real-time continuous glucose monitoring for hospitalized patients with diabetes: a multicenter, single-arm, feasibility trial","volume":"25","author":"Davis","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib91","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eprac.2024.07.012","article-title":"Automated insulin delivery technology in the hospital: update on safety and efficacy data","volume":"30","author":"Thompson","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/j.eprac.2026.06.011_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110897","article-title":"Glycemic control metrics in a cohort of hospitalized patients with type 1 diabetes using hybrid closed-loop and advanced hybrid closed-loop systems","volume":"204","author":"G\u00f3mez Medina","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib93","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJMoa1805233","article-title":"Closed-loop insulin delivery for glycemic control in noncritical care","volume":"379","author":"Bally","year":"2018","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.eprac.2026.06.011_bib94","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2337\/dc22-0438","article-title":"Perioperative fully closed-loop insulin delivery in patients undergoing elective surgery: an open-label, randomized controlled trial","volume":"45","author":"Herzig","year":"2022","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15092","article-title":"Implementation of fully closed-loop insulin delivery for inpatients with diabetes: real-world outcomes","volume":"40","author":"Boughton","year":"2023","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib96","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2213-8587(19)30061-0","article-title":"Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial","volume":"7","author":"Boughton","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib97","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1177\/19322968221137335","article-title":"Insulin pumps and hybrid close loop systems within hospital: a scoping review and practical guidance from the Joint British Diabetes Societies for Inpatient Care","volume":"17","author":"Avari","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib98","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.2337\/dc22-2297","article-title":"A randomized crossover trial to compare automated insulin delivery (the artificial pancreas) with carbohydrate counting or simplified qualitative meal-size estimation in type 1 diabetes","volume":"46","author":"Haidar","year":"2023","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib99","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/dc22-1692","article-title":"Simplified meal announcement versus precise carbohydrate counting in adolescents with type 1 diabetes using the MiniMed 780G advanced hybrid closed loop system: a randomized controlled trial comparing glucose control","volume":"46","author":"Petrovski","year":"2023","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.eprac.2026.06.011_bib100","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1089\/dia.2022.0162","article-title":"Efficacy and safety of tandem control IQ without user-initiated boluses in adults with uncontrolled type 1 diabetes","volume":"24","author":"Akturk","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib101","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1932296820955168","article-title":"Training and support for hybrid closed-loop therapy","volume":"16","author":"Boughton","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib102","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.paed.2021.01.002","article-title":"Insulin pump therapy","volume":"31","author":"Peters","year":"2021","journal-title":"Paediatr Child Health"},{"issue":"14","key":"10.1016\/j.eprac.2026.06.011_bib103","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.13994","article-title":"Association of insulin pump therapy vs insulin injection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes","volume":"318","author":"Karges","year":"2017","journal-title":"JAMA"},{"issue":"9950","key":"10.1016\/j.eprac.2026.06.011_bib104","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"issue":"7339","key":"10.1016\/j.eprac.2026.06.011_bib105","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.324.7339.705","article-title":"Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials","volume":"324","author":"Pickup","year":"2002","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib106","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1080\/17425247.2017.1313831","article-title":"A novel pen-based Bluetooth-enabled insulin delivery system with insulin dose tracking and advice","volume":"14","author":"Bailey","year":"2017","journal-title":"Expert Opin Drug Deliv"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib107","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/cd22-0126","article-title":"First real-world experience with Bigfoot Unity: a 6-month retrospective analysis","volume":"41","author":"Baliga","year":"2023","journal-title":"Clin Diabetes"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib108","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/19322968241301760","article-title":"Dose accuracy and reliability of a connected insulin pen system","volume":"20","author":"Backfish","year":"2026","journal-title":"J Diabetes Sci Technol"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib109","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/dc23-2176","article-title":"Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting","volume":"47","author":"Danne","year":"2024","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2337\/dc22-0525","article-title":"Efficacy of a connected insulin pen cap in people with noncontrolled type 1 diabetes: a multicenter randomized clinical trial","volume":"46","author":"Gomez-Peralta","year":"2023","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib111","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/dc18-1631","article-title":"Nonadherence to insulin therapy detected by Bluetooth-enabled pen cap is associated with poor glycemic control","volume":"42","author":"Munshi","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib112","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/19322968211033837","article-title":"Efficacy of a smart insulin pen cap for the management of patients with uncontrolled type 2 diabetes: a randomized cross-over trial","volume":"17","author":"Galindo","year":"2023","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib113","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s12325-023-02478-1","article-title":"Clinical, economic, and patient-reported benefits of connected insulin pen systems: a systematic literature review","volume":"40","author":"Cranston","year":"2023","journal-title":"Adv Ther"},{"issue":"3","key":"10.1016\/j.eprac.2026.06.011_bib114","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/1932296820983863","article-title":"Digital diabetes management: a literature review of smart insulin pens","volume":"16","author":"Heinemann","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/dia.2024.0356","article-title":"A telehealth program using continuous glucose monitoring and a connected insulin pen cap in nursing homes for older adults with insulin-treated diabetes: the Trescasas study","volume":"27","author":"Gomez-Peralta","year":"2025","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"10.1016\/j.eprac.2026.06.011_bib116","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.3390\/jcm14061794","article-title":"Advancing telemedicine using smart insulin pens with continuous glucose monitoring and telecommunication systems: a case series","volume":"14","author":"Singh","year":"2025","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib117","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s13300-020-00980-1","article-title":"Smart insulin pens are associated with improved clinical outcomes at lower cost versus standard-of-care treatment of type 1 diabetes in Sweden: a cost-effectiveness analysis","volume":"12","author":"Jendle","year":"2021","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib118","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40271-022-00610-x","article-title":"Patients' preferences for connected insulin pens: A discrete choice experiment among patients with type 1 and type 2 diabetes","volume":"16","author":"Seo","year":"2023","journal-title":"Patient"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib119","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/pharmaceutics16070944","article-title":"Advancements in insulin pumps: a comprehensive exploration of insulin pump systems, technologies, and future directions","volume":"16","author":"Rimon","year":"2024","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.eprac.2026.06.011_bib120","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s13300-024-01598-3","article-title":"Addressing the burden of multiple daily insulin injections in type 2 diabetes with insulin pump technology: a narrative review","volume":"15","author":"Brixner","year":"2024","journal-title":"Diabetes Ther"},{"issue":"2","key":"10.1016\/j.eprac.2026.06.011_bib121","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s40801-016-0075-4","article-title":"The clinical and economic impact of the V-Go(\u00ae) disposable insulin delivery device for insulin delivery in patients with poorly controlled diabetes at high risk","volume":"3","author":"Lajara","year":"2016","journal-title":"Drugs Real World Outcomes"},{"key":"10.1016\/j.eprac.2026.06.011_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109858","article-title":"Patch pumps: what are the advantages for people with diabetes?","volume":"187","author":"Kulzer","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib123","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40801-019-00173-8","article-title":"Effectiveness of V-Go(\u00ae) for patients with type 2 diabetes in a real-world setting: a prospective observational study","volume":"7","author":"Grunberger","year":"2020","journal-title":"Drugs Real World Outcomes"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib124","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s12325-018-0703-3","article-title":"Clinical benefits over time associated with use of V-Go wearable insulin delivery device in adult patients with diabetes: a retrospective analysis","volume":"35","author":"Sutton","year":"2018","journal-title":"Adv Ther"},{"issue":"5","key":"10.1016\/j.eprac.2026.06.011_bib125","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/19322968211016513","article-title":"Comparing patch vs pen bolus insulin delivery in type 2 diabetes using continuous glucose monitoring metrics and profiles","volume":"16","author":"Bergenstal","year":"2022","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"10.1016\/j.eprac.2026.06.011_bib126","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/19322968211008185","article-title":"Feasibility of continuous ketone monitoring in subcutaneous tissue using a ketone sensor","volume":"15","author":"Alva","year":"2021","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl 7 Suppl 7","key":"10.1016\/j.eprac.2026.06.011_bib127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/dom.15921","article-title":"Continuous ketone monitoring: Exciting implications for clinical practice","volume":"26","author":"Kong","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.eprac.2026.06.011_bib128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(25)00331-6","article-title":"Continuous ketone monitoring for people with diabetes: international expert recommendations on the application of a new technology","volume":"14","author":"Dhatariya","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2026.06.011_bib129","doi-asserted-by":"crossref","DOI":"10.2196\/70429","article-title":"Clinical improvements from telemedicine interventions for managing type 2 diabetes compared with usual care: systematic review, meta-analysis, and meta-regression","volume":"14","author":"Jiang","year":"2026","journal-title":"JMIR Mhealth Uhealth"},{"key":"10.1016\/j.eprac.2026.06.011_bib130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17538157.2025.2609747","article-title":"Technology-driven diabetes management: a review of digital therapeutics, mobile apps, and clinical evidence","author":"Bhattacharya","year":"2026","journal-title":"Inform Health Soc Care"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26010463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X26010463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:10:11Z","timestamp":1793959811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X26010463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":128,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1530891X26010463"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2026.06.011","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"American Association of Clinical Endocrinology Consensus Statement: Use of Diabetes Technology for Management of Adults with Diabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2026.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}